Literature DB >> 32651007

Risk factors for mortality from severe community-acquired pneumonia in hospitalized children transferred to the pediatric intensive care unit.

Tingting Shi1, Chen Chen2, Li Huang3, Huifeng Fan4, Gen Lu5, Diyuan Yang6, Changan Zhao7, Dongwei Zhang8.   

Abstract

BACKGROUND: Some children hospitalized due to severe community-acquired pneumonia (CAP) require to the pediatric intensive care unit (PICU) because of severe complications. The purpose of this study was to identify the risk factors for mortality in this patient population.
METHODS: This study evaluated the medical records of 113 hospitalized children with severe CAP, who were transferred to the PICU within 48 h of admission at the Guangzhou Women and Children's Medical Center between 2013 and 2017.
RESULTS: The study group consisted of 87 boys (77%) and 26 girls (33%), aged between 1 month and 9 years; 72.6% (82/113) of patients were aged <12 months. The mortality rate was 12.3% (14/113). The most common viral and bacterial pathogens isolated were adenovirus (17.7%, 20/113) and Haemophilus influenzae (8.8%, 10/113). Wheezing, cyanosis, oxygen saturation <90%, Pediatric Early Warning Score (PEWS) >3 on admission, not receiving corticosteroid therapy prior to admission, the need for mechanical ventilation, septic shock, multi-organ dysfunction (MODS), and acute renal failure (ARF) occurring prior to transfer to the PICU, increased alanine aminotransferase (ALT) and aspartate transaminase (AST) levels, and decreased hemoglobin and albumin (ALB) levels were associated with mortality (P < 0.05). Non-survivors were more likely to have an oxygen saturation <90% on admission and lower levels of ALB prior to transfer to the PICU than survivors (P < 0.05).
CONCLUSIONS: Our results showed that hospitalized children with severe CAP who were transferred to the PICU within 48 h of hospital admission were mainly aged <1 year. Additionally, an oxygen saturation <90% and decreased ALB levels were early prognostic variables independently associated with death.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  community-acquired pneumonia; hospitalized children; pediatric intensive care unit; risk factors

Mesh:

Year:  2020        PMID: 32651007     DOI: 10.1016/j.pedneo.2020.06.005

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  6 in total

1.  Aerosol inhalation of ambroxol hydrochloride combined with terbutaline can promote recovery of children with severe pneumonia.

Authors:  Fengfei Yu; Chengling Li; Maohua Liu; Tong Shen; Chengjun Liu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Immune Response against Adenovirus in Acute Upper Respiratory Tract Infections in Immunocompetent Children.

Authors:  Giovanni Battista Biserni; Arianna Dondi; Riccardo Masetti; Jessica Bandini; Ada Dormi; Francesca Conti; Andrea Pession; Marcello Lanari
Journal:  Vaccines (Basel)       Date:  2020-10-13

3.  Combined Neutrophil-to-Lymphocyte Ratio and CURB-65 Score as an Accurate Predictor of Mortality for Community-Acquired Pneumonia in the Elderly.

Authors:  Ding-Yun Feng; Xiao-Ling Zou; Yu-Qi Zhou; Wen-Bin Wu; Hai-Ling Yang; Tian-Tuo Zhang
Journal:  Int J Gen Med       Date:  2021-03-30

4.  Severe pneumonia: Treatment outcome and its determinant factors among under-five patients, Jimma, Ethiopia.

Authors:  Kenenisa Tegenu; Gelane Geleto; Desalew Tilahun; Ebissa Bayana; Bayisa Bereke
Journal:  SAGE Open Med       Date:  2022-02-21

5.  Combination of Hemoglobin-for-Age Z-Score and Plasma Hepcidin Identified as a Novel Predictor for Kawasaki Disease.

Authors:  Ya-Ling Yang; Ho-Chang Kuo; Kuang-Den Chen; Chi-Hsiang Chu; Kuang-Che Kuo; Mindy Ming-Huey Guo; Ling-Sai Chang; Ying-Hsien Huang
Journal:  Children (Basel)       Date:  2022-06-18

Review 6.  Potential Diagnostic and Prognostic Biomarkers for Adenovirus Respiratory Infection in Children and Young Adults.

Authors:  Giovanni Battista Biserni; Sara Scarpini; Arianna Dondi; Carlotta Biagi; Luca Pierantoni; Riccardo Masetti; Sugitha Sureshkumar; Alessandro Rocca; Marcello Lanari
Journal:  Viruses       Date:  2021-09-21       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.